Clinical Trials in Seattle

Showing 21-40 of 8,929 trials

One-step HCV RNA Testing Among SSP Participants (HOT Study)

NCT06634342

The HOT (HCV One-step Test) Study is an observational prospective study to evaluate the use of a recently FDA-approved point-of-care RNA test for hepatitis C virus (HCV) in a sample of clients of a syringe services program (SSP). The investigators aim to answer the following questions: 1\. How will point-of-care HCV RNA testing with the Xpert HCV test, provided at an SSP, affect how people who use drugs receive their results, get linked to HCV care services, and initiate and complete HCV treatment? 2: What are the most effective ways to implement point of care HCV RNA testing in syringe services programs?

Testing Effect of Intervention

University of Washington200 participantsStarted Feb 2025

Seattle, Washington, United States

TERMINATEDPhase 3< 1 mile

Study of Tecovirimat for Human Mpox Virus

NCT05534984

The purpose of this study was to see if tecovirimat is safe and successful at treating mpox. The main questions were whether tecovirimat reduced time to lesion resolution and pain compared to placebo (no treatment).

MPOX

National Institute of Allergy and Infectious Diseases (NIAID)719 participantsStarted Sep 2022

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +51 more locations

One-step HCV RNA Testing Among SSP Participants (HOT Study)

Study of Tecovirimat for Human Mpox Virus

Find Trials by Condition in Seattle

An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

Clinical Evaluation of Visby Medical Men's Sexual Health Test

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Relationship of Exercise, Sleep, and Inflammation Markers in People Living With HIV

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

A Gaucher Disease Gene Therapy Trial With FLT201